Leucogen
Feline leukaemia vaccine (inactivated)
Table of contents
Overview
Leucogen is a veterinary vaccine used in cats from eight weeks of age to protect them against feline leukaemia. Feline leukaemia is an infectious disease of cats which affects the immune system and is caused by the feline leukaemia virus (FeLV). Signs of the disease can include loss of appetite, weight loss, poor fur condition, fever, pale gums and diarrhoea; cats persistently infected with the virus may spread it to other cats. The vaccine is used to prevent the disease signs and persistent viraemia (the presence of FeLV in the blood).
The medicine contains a protein from the outer layer of FeLV.
Authorisation details
Product details | |
---|---|
Name |
Leucogen
|
Agency product number |
EMEA/V/C/000144
|
Active substance |
purified p45 FeLV-envelope antigen
|
International non-proprietary name (INN) or common name |
Feline leukaemia vaccine (inactivated)
|
Species |
Cats
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI06AA01
|
Publication details | |
---|---|
Marketing-authorisation holder |
Virbac S.A.
|
Revision |
8
|
Date of issue of marketing authorisation valid throughout the European Union |
17/06/2009
|
Contact address |
1ère Avenue 2065 M - L.I.D. |
Product information
07/10/2021 Leucogen - EMEA/V/C/000144 - IG-1409
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for felidae
-
Inactivated viral vaccines
-
feline leukaemia virus
Therapeutic indication
Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.